1-8 of 8
Maura Lima Pereira Bueno
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PIM447, a Pan-PIM Kinase Inhibitor, in Combination with Venetoclax Exerts a Potent Anti-Tumor Activity in the Bone Marrow Niche

Fernanda Marconi Roversi, Maura Lima Pereira Bueno, Samara de Sousa Mariano, Fernanda Soares Niemann, Adriana da Silva Santos Duarte, Audrey Bastos, Nádia Ghinelli Amôr, Irene Santos, Jose Andres Yunes, Sandra Pinho, Sara Teresinha Olalla Saad
Journal: Blood
Blood (2024) 144 (Supplement 1): 3589.
https://doi.org/10.1182/blood-2024-201572
Published: 2024
Journal Articles

Novel MET Inhibitors Provide a Therapeutic Opportunity for AML By Overcoming the Protective Action of the Bone Marrow Niche

Maura Lima Pereira Bueno, Charles Ayemoba, Anna M Di Staulo, Sen Zhang, Fernanda Soares Niemann, Nádia Ghinelli Amôr, Irene Santos, Adriana da Silva Santos Duarte, Audrey Bastos, Sara Teresinha Olalla Saad, Sandra Pinho, Fernanda Marconi Roversi
Journal: Blood
Blood (2024) 144 (Supplement 1): 4968.
https://doi.org/10.1182/blood-2024-201077
Published: 2024
Journal Articles

Inhibition of MET Tyrosine Kinase Provides a Strategy for Targeting the Inflammatory Tumor Microenvironment

Maura Lima Pereira Bueno, Irene Santos, Nádia Ghinelli Amôr, Adriana Duarte da Silva Santos, Audrey Bastos, Karla Priscila Ferro, Sara Teresinha Olalla Saad, Fernanda Marconi Roversi
Journal: Blood
Blood (2023) 142 (Supplement 1): 2264.
https://doi.org/10.1182/blood-2023-185204
Published: 2023
Journal Articles

HGF Regulation in the Tumor-Supportive Microenvironment Combined with Pan-PIM Kinases Inhibition in Malignant Cells As a Multi-Target Approach for Acute Myeloid Leukemia

Fernanda Marconi Roversi, Maura Lima Pereira Bueno, Fernanda Soares Niemann, Irene Santos, Nádia Ghinelli Amôr, Adriana Duarte da Silva Santos, Audrey Bastos, Sara Teresinha Olalla Saad
Journal: Blood
Blood (2023) 142 (Supplement 1): 3641.
https://doi.org/10.1182/blood-2023-185179
Published: 2023
Journal Articles

Combined Inhibition of MCL1 By AZD5991 and BCL2/Bclxl By AZD4320 As Promising Strategies to Overcome Acute Leukemia Tumor Burden and Niche Chemoresistance

Maura Lima Pereira Bueno, Leonardo Artico, Adriana Silva Santos Duarte, Audrey Basso, Jose Andres Yunes, Sara T. Olalla Saad, Fernanda Marconi Roversi
Journal: Blood
Blood (2022) 140 (Supplement 1): 4943–4944.
https://doi.org/10.1182/blood-2022-158620
Published: 2022
Journal Articles

HCK Inhibition Displays Antineoplastic Activity on Acute Leukemia and Promotes Immune Regulation of the Bone Marrow Tumor Microenvironment

Fernanda Marconi Roversi, Maura Lima Pereira Bueno, Audrey Basso, Adriana Silva Santos Duarte, Juliete A.F. Silva, Sara T Olalla Saad
Journal: Blood
Blood (2022) 140 (Supplement 1): 7806–7807.
https://doi.org/10.1182/blood-2022-158579
Published: 2022
Journal Articles

A Novel WNT5A-Mimicking Peptide Affects Leukemia Cell Survival in the Bone Marrow Microenvironment

Fernanda Marconi Roversi, Maura Lima Pereira Bueno, Rafael Gonçalves Barbosa Gomes, Guilherme Rossi Assis-Mendonça, Paulo Latuf Filho, Adriana Silva Santos Duarte, Sara T Olalla Saad
Journal: Blood
Blood (2021) 138 (Supplement 1): 2949.
https://doi.org/10.1182/blood-2021-148744
Published: 2021
Journal Articles

A Novel Chemical Compound Inhibiting Hematopoietic Cell Kinase (iHCK) Has a Synergic Effect with Azacytidine (Aza) or Cytarabine (Ara-C) for Acute Myeloid Leukemia Treatment

Fernanda Marconi Roversi, Maura Lima Pereira Bueno, undergraduate, Cristiane Okuda Torello, PhD, Fernanda I Della Via, MSc, Renata Giardini Rosa, PhD, Juares Ednaldo Romero Bianco, PhD, Adriana Silva Santos Duarte, PhD, Eduardo M Rego, MD PhD, Alessio Molinari, Maurizio Botta, Sara T Olalla Saad, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4650.
https://doi.org/10.1182/blood-2019-128959
Published: 2019